Detailed answers about GLOX THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was GLOX THERAPEUTICS LIMITED founded?
GLOX THERAPEUTICS LIMITED was officially incorporated on 27 February 2023 and is registered under company number SC760230. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GLOX THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GLOX THERAPEUTICS LIMITED?
GLOX THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GLOX THERAPEUTICS LIMITED do?
GLOX THERAPEUTICS LIMITED operates in the following sectors: 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is GLOX THERAPEUTICS LIMITED's registered address?
The registered office address of GLOX THERAPEUTICS LIMITED is JOHN ARBUTHNOTT BUILDING STRATHCLYDE UNIVERSITY OF PHARMACY & BIOMEDICAL, 161 CATHEDRAL STREET, GLASGOW, SCOTLAND, G4 0RE. This is the official address filed with Companies House for legal and statutory correspondence.
Is GLOX THERAPEUTICS LIMITED financially stable?
The most recent accounts for GLOX THERAPEUTICS LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.